{
    "nctId": "NCT02432950",
    "briefTitle": "Pancreatic Nutritional Program for Weight Loss in Overweight/Obese Patients With Stage I-III Breast Cancer",
    "officialTitle": "PANCREATIC NUTRITIONAL PROGRAM (PNP): A Novel Weight Reduction Program in Overweight/Obese Breast Cancer Survivors",
    "overallStatus": "COMPLETED",
    "conditions": "Obesity, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 21,
    "primaryOutcomeMeasure": "Change in body weight",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with early-stage breast cancer (stage I-III)\n* Patients who have or have not undergone chemotherapy are both eligible; if the patient has undergone chemotherapy she must have completed adjuvant chemotherapy for \\>= 3 months and =\\< 5 years prior to study enrollment\n* Postmenopausal women defined by either: natural menopause with at least one year since last menses, or chemotherapy-induced menopause with at least one year since last menses and follicle-stimulating hormone (FSH) and estradiol levels within the postmenopausal range\n* Body mass index (BMI) of 25-33 kg/m\\^2\n* Patients must be willing to adhere to the PNP intervention and the entire 6-month study\n* All patients must have the ability and the willingness to sign a written informed consent\n\nExclusion Criteria:\n\n* Patients who are diabetic\n* Patients whose BMI falls outside the eligible range (\\< 25 kg/m\\^2 or \\> 33 kg/m\\^2)\n* Patients with stage IV breast cancer\n* Patients with Rheumatoid Arthritis and other inflammatory diseases that would impact correlative studies",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}